Synthego Bridges Critical Preclinical Gap to Accelerate CRIS

Synthego Bridges Critical Preclinical Gap to Accelerate CRISPR-based Cell and Gene Therapies

/PRNewswire/ -- Synthego, a leading provider of genome engineering solutions, today announced the launch of its IND-enabling (INDe) gRNAs, a transformative...

Related Keywords

Prnewswire Synthego , Paul Dabrowski , , Investigational New Drug , Synthego ,